Imad Naasani

1.2k total citations
26 papers, 1.0k citations indexed

About

Imad Naasani is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Imad Naasani has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Physiology. Recurrent topics in Imad Naasani's work include Drug Transport and Resistance Mechanisms (8 papers), Telomeres, Telomerase, and Senescence (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Imad Naasani is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Telomeres, Telomerase, and Senescence (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). Imad Naasani collaborates with scholars based in Japan, United Kingdom and United States. Imad Naasani's co-authors include Hiroyuki Seimiya, Takashi Tsuruo, Tomoko Oh‐hara, Takao Yamori, T Tsuruo, Elnaz Yaghini, Alexander J. MacRobert, Wan Yong Feng, Jeffrey S. Johnston and Kenneth Chun‐Ho Chan and has published in prestigious journals such as Biomaterials, Biochemical and Biophysical Research Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Imad Naasani

26 papers receiving 981 citations

Peers

Countries citing papers authored by Imad Naasani

Since Specialization

Citations

This map shows the geographic impact of Imad Naasani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imad Naasani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imad Naasani more than expected).

Fields of papers citing papers by Imad Naasani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imad Naasani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imad Naasani. The network helps show where Imad Naasani may publish in the future.

Co-authorship network of co-authors of Imad Naasani

This figure shows the co-authorship network connecting the top 25 collaborators of Imad Naasani. A scholar is included among the top collaborators of Imad Naasani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imad Naasani. Imad Naasani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Establishing the Pharmacokinetics of Genetic Vaccines is Essential for Maximising their Safety and Efficacy 2022 ·Clinical Pharmacokinetics ·Imad Naasani	10
2	Population pharmacokinetic modelling of indium-based quantum dot nanoparticles: preclinical in vivo studies 2020 ·European Journal of Pharmaceutical Sciences ·Elnaz Yaghini, (unknown), Andrew Pilling, (unknown), (unknown), Imad Naasani, Mohammed Keshtgar, Alexander J. MacRobert, Oscar Della Pasqua	15
3	COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics 2020 ·SLAS DISCOVERY ·Imad Naasani	13
4	In vivo biodistribution and toxicology studies of cadmium-free indium-based quantum dot nanoparticles in a rat model 2018 ·Nanomedicine Nanotechnology Biology and Medicine ·Elnaz Yaghini, (unknown), Andrew Pilling, Imad Naasani, Alexander J. MacRobert	62
5	In vivo biodistribution studies and ex vivo lymph node imaging using heavy metal-free quantum dots 2016 ·Biomaterials ·Elnaz Yaghini, (unknown), Alix Le Marois, Klaus Suhling, Imad Naasani, Alexander J. MacRobert	45
6	Fighting cancer with quantum dots 2016 ·IEEE Spectrum ·Imad Naasani	1
7	Screening with COMPARE Analysis for Telomerase Inhibitors 2003 ·Humana Press eBooks ·Imad Naasani, Takao Yamori, Takashi Tsuruo	3
8	Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. 2003 ·PubMed ·Imad Naasani, Fujiko Oh-hashi, Tomoko Oh‐hara, Wan Yong Feng, Jeffrey S. Johnston, Kenneth Chun‐Ho Chan, Takashi Tsuruo	173
9	Telomerase inhibitors: Forcing the end to put an end 2000 ·Drug News & Perspectives ·Imad Naasani	1
10	Hypoxia Up-Regulates Telomerase Activity via Mitogen-Activated Protein Kinase Signaling in Human Solid Tumor Cells 1999 ·Biochemical and Biophysical Research Communications ·Hiroyuki Seimiya, (unknown), Tomoko Oh‐hara, Akihiro Tomida, Imad Naasani, Takashi Tsuruo	77
11	FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. 1999 ·PubMed ·Imad Naasani, Hiroyuki Seimiya, Takao Yamori, T Tsuruo	140
12	Purification and liposomal reconstitution of the oligopeptide transport activity in rat renal cortex using ceftibuten-affinity chromatography 1998 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), Imad Naasani, Takayuki Kikuchi, Mitsuru Sugawara, Michiya Kobayashi, Naonori Kohri, Katsumi Miyazaki	1
13	Telomerase Inhibition, Telomere Shortening, and Senescence of Cancer Cells by Tea Catechins 1998 ·Biochemical and Biophysical Research Communications ·Imad Naasani, Hiroyuki Seimiya, Takashi Tsuruo	201
14	Purification by ceftibuten-affinity chromatography and the functional reconstitution of oligopeptide transporter(s) in rat intestinal brush-border membrane 1998 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Ken Iseki, (unknown), Takayuki Kikuchi, Imad Naasani, Mitsuru Sugawara, Michiya Kobayashi, Naonori Kohri, Katsumi Miyazaki	8
15	Transport mechanisms of nucleosides and the derivative, 6-mercaptopurine riboside across rat intestinal brush-border membranes 1996 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), Mitsuru Sugawara, (unknown), Imad Naasani, (unknown), (unknown)	13
16	Solubilization and reconstitution characteristics of the carrier protein(s) responsible for the transport of ceftibuten, a substrate for the oligopeptide transporters, in rat renal brush-border membrane 1996 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Imad Naasani, Takayuki Kikuchi, Mitsuru Sugawara, (unknown), Ken Iseki, Katsumi Miyazaki	7
17	Uptake of 6‐Mercaptopurine Riboside via the Nucleoside Transporter in the Human Intestinal Brush‐border Membrane 1995 ·Pharmacy and Pharmacology Communications ·Ken Iseki, Imad Naasani, Mitsuru Sugawara, (unknown), Michiya Kobayashi, Katsumi Miyazaki	1
18	Comparison of the transport characteristics of ceftibuten in rat renal and intestinal brush-border membranes 1995 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Imad Naasani, Kaori Sato, Ken Iseki, Mitsuru Sugawara, (unknown), Katsumi Miyazaki	20
19	Transport Mechanism of Ceftibuten, a Dianionic Cephem, in Rat Renal Brush-Border Membrane 1995 ·Pharmaceutical Research ·Imad Naasani, Mitsuru Sugawara, (unknown), Ken Iseki, (unknown)	9
20	Improving the Oral Bioavailability of Sulpiride by Sodium Oleate in Rabbits 1995 ·Journal of Pharmacy and Pharmacology ·Imad Naasani, Naonori Kohri, Ken Iseki, Katsumi Miyazaki	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact